Genmab — Februar 2017
-
Naturligvis er man skuffede over manglende tech aftale. Men det vigtigste for 2017 er stigende salgstal måned for måned, samt ikke mindst at Carina studiet i NHL kommer ud med positive data senere på året. Derudover er tisotumab data også i andet halvår vigtige. Lad os holde det for øje nu

-
Hun ligger stadig med et latterligt kursmål på 6xx!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind